Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 24, 2001

View Archived Issues

Study In Twins Points To Role Of Genetic Heart Disease Factors

London Exchange Might Ease Listing Rules For Young Firms

GPC, Byk Gulden Collaborate In Deal Worth Up To US$100M

European Bioethics Committee Starts Work, Elects President

Belgian Firms Tibotec, Virco Plan To Add Mass Via Merger

Strong Placebo Effect In Phase II Causes Failed Phytopharm Trial

IsoTis Completes Implants Of Autologous Living Bone Tissue

European Pharma Industry Calls For New Evaluation Structure

Other News To Note

Biotran Completes Australian IPO To Fund Diagnostics, HIV Product

NiCox Reveals 'Aggressive' Plan For Compounds In Coming Year

Cerep, Four European Companies Align To Create Compound Library

Genset Subscribes To Celera Products For Genomics Work

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 24, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026